Search Results 101-110 of 17449 for colitis

  1. Study of GS-5290 in Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    Study of GS-5290 in Participants With Moderately-to-Severely Active Ulcerative Colitis · Overview · Participation eligibility · Participating Mayo Clinic locations.

  2. Evaluation of the Relationship Between Pouch Function and Pouch Inflammation in Patients with Ulcerative Colitis - Mayo Clinic

    Evaluation of the Relationship Between Pouch Function and Pouch Inflammation in Patients with Ulcerative Colitis · Overview · Participation eligibility.

  3. Ileoanal anastomosis (J-pouch) surgery - Mayo Clinic

    This surgery removes the large intestine. It's often done to treat ulcerative colitis and other bowel conditions.

  4. A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.

  5. A Study to Evaluate the Effectiveness, Safety and Movement of Ustekinumab in Pediatric Patients with Ulcerative Colitis - Mayo Clinic

    The global primary objectives of this study are, in pediatric participants with moderately to severely active ulcerative colitis (UC):. To evaluate the efficacy ...

  6. First Efficacy Study of Investigational Antiviral Therapy for COVID-19 Infection in Patients with IBD - Mayo Clinic News Network

    IBD encompasses a range of disorders involving inflammation of the digestive tract, including ulcerative colitis and Crohn's disease. Symptoms for both ...

  7. A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis - Mayo Clinic

    The study proposes to assess whether compared to placebo, CP-690,550 is effective, safe, and tolerable maintenance therapy in subjects with Ulcerative Colitis ( ...

  8. Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients with Ulcerative Colitis (PROPHETIC Study) - Mayo Clinic

    Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients with Ulcerative Colitis (PROPHETIC Study) · Overview · Participation ...

  9. Infliximab-abda (intravenous route) - Mayo Clinic

    Description. Infliximab-abda injection is used in adults to treat Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, ...

  10. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis · Overview · Participation eligibility.